
HRW promotes Gillian Newbold to the board
pharmafile | April 7, 2011 | Appointment | Medical Communications |Â Â apppointment, medical communicationsÂ
Healthcare research agency HRW has promoted Gillian Newbold to its board of directors.
Gillian joined the Oxfordshire, UK-based company in 2009 and is currently its research director (strategy).
She joins chairman Prof. David Thomson, managing director Caroline Jameson and deputy managing director Jeanette Kaye on the board, and HRW said Gillian’s passion for research and strategic thinking have made a significant contribution to its continued growth and success.
Related Content

Rare diseases – spinal muscular atrophy
Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …






